https://www.socictopen.socict.org/files/original/2f7994ef8b9942904a4511233d8c5640.pdf ff0c8cd7cf21861c9b62ceb8feeebf5f Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects. Creator An entity primarily responsible for making the resource Tingting Qiu, Yitong Wang, Shuyao Liang, Ru Han, Mondher Toumi Description An account of the resource Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues, the challenges in market authorisation, and price and reimbursement of CGTs were amplified. Nevertheless, it is encouraging to see that some CGT developers are adapting their efforts toward the development of promising COVID-19-related therapeutics and vaccines. Manufacturing resilience, digitalisation, telemedicine, value-based pricing, and innovative payment mechanisms will be increasingly harnessed to ensure that market access of CGTs is not severely disrupted. Date A point or period of time associated with an event in the lifecycle of the resource 2021 Subject The topic of the resource covid-19, regulatory, health technology assessment, Cell and gene therapies Identifier An unambiguous reference to the resource within a given context 10.1016/j.drudis.2021.04.020 Source A related resource from which the described resource is derived Drug discovery today